NTRA
Natera, Inc.
NTRA lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NTRA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
NTRA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NTRA PE Valuation
NTRA has no meaningful PE right now: it lost money over the past year.
NTRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NTRA's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
NTRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.13 | +$1.16 |
| Q2 2026 | -$1.35 | +$0.56 |
| Q1 2026 | -$1.62 | -$0.15 |
| Q4 2025 | -$1.52 | +$0.01 |
| Q3 2025 | -$2.29 | -$0.54 |
| Q2 2025 | -$1.91 | +$0.53 |
| Q1 2025 | -$1.47 | +$1.64 |
| Q4 2024 | -$1.53 | +$2.25 |
NTRA is still losing money, but far less than before: $1.13 per share over the past year, against $6.10 at its worst in mid-2022.
NTRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $794M | +34% |
| Q2 2026 | $752.8M | +38% |
| Q1 2026 | $696.6M | +39% |
| Q4 2025 | $665.5M | +40% |
| Q3 2025 | $592.2M | +35% |
| Q2 2025 | $546.6M | +32% |
| Q1 2025 | $501.8M | +36% |
| Q4 2024 | $476.1M | +53% |
NTRA's revenue has grown year over year every quarter since late 2020: $794M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.6% | +7.9 points |
| Q2 2026 | -10% | +10 points |
| Q1 2026 | -13% | +2.4 points |
| Q4 2025 | -3.4% | +10 points |
| Q3 2025 | -16% | -7.5 points |
| Q2 2025 | -20% | -9.6 points |
| Q1 2025 | -16% | +4.4 points |
| Q4 2024 | -14% | +14 points |
NTRA's operating margin was −8.6% last quarter, up 7.9 points from the same quarter a year ago, near the top of its range since 2019.
NTRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.3M | -86% |
| Q2 2026 | -$8.6M | -174% |
| Q1 2026 | $18M | -20% |
| Q4 2025 | $37.8M | +8.8% |
| Q3 2025 | $37M | +4.3% |
| Q2 2025 | $11.7M | +$19.4M |
| Q1 2025 | $22.6M | +239% |
| Q4 2024 | $34.8M | +$102.4M |
NTRA has burned cash in most quarters: $52M over the past year, down 51% from the year before.
NTRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +788K shares |
| 1 year | +5% | +6.9M shares |
| 3 years | +25% | +28.9M shares |
| 5 years | +56% | +51.5M shares |
| Available history | +107% | +74.5M shares |
NTRA has 144M diluted shares, up 5% from a year ago.
NTRA Net Leverage
NTRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NTRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 43.5 | Neutral |
NTRA's weekly RSI is 51 (neutral) and its Stochastic is 44 (neutral).
NTRA PE vs Healthcare Sector
NTRA has no meaningful PE right now: it lost money over the past year.
NTRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $383.6 | 16% below |
| 20 week MA | $336.8 | 4.1% below |
| 50 week MA | $263.7 | 22% above |
| 100 week MA | $214.8 | 50% above |
| 200 week MA | $147.1 | 120% above |
NTRA has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 120% above its 200-week average.
NTRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.7 | $111.7 | +232% |
| 2021 | $111.7 | $93.8 | -16% |
| 2022 | $93.8 | $41.5 | -56% |
| 2023 | $41.5 | $62.6 | +51% |
| 2024 | $62.6 | $160.3 | +156% |
| 2025 | $160.3 | $233.7 | +46% |
| 2026 YTD | $233.7 | $322.9 | +38% |
NTRA's yearly returns have swung widely, from +232% in 2020 to −56% in 2022. It's up 38% so far in 2026.